Baxter International Inc. (BAX) Stock Analysis

Baxter International Inc. (BAX) Stock Analysis — AI Research | MarketCI

BAX

Market Closed

Baxter International Inc.

NYSEHealthcare Medical - Instruments & Supplies

38.00K employees

CEO: Andrew Hider

Founded: 1981

$19.89

+$0.00(+NaN%)

Market Cap

10.27B

Beta

0.64

52W Range

N/A

Dividend Yield

1.01%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

BAX Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for BAX built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

28.57%

Score

2/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$3.06

AI Price Target

Machine learning • Price prediction

$17.75

Market Sentiment

News & social media analysis

0.05

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

2.08

Quality Score

Financial strength rating

5.00

AI Investment Grade

Deep analysis of filings & news

62.00

Key Investment Highlights

Important factors affecting BAX investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

50.00% Good

Conditions Met

20.00/40.00

Due Diligence Score

50.00%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Pass
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions